A RXR ligand 6-OH-11-O-hydroxyphenanthrene with antitumour properties enhances (-)-epigallocatechin-3-gallate activity in three human breast carcinoma cell lines

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Farabegoli, Fulvia ^a   Govoni, Marzia ^a   Ciavarella, Carmen ^a   Orlandi, Marina ^a   Papi, Alessio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

6 OH 11 O HYDROXYPHENANTHRENE; ANTINEOPLASTIC AGENT; EPIGALLOCATECHIN GALLATE; LAMININ RECEPTOR; LIGAND; MESSENGER RNA; PROTEIN KINASE B; PROTEIN P47; RETINOID X RECEPTOR; RETINOID X RECEPTOR GAMMA; TRANSCRIPTION FACTOR FKHRL1; UNCLASSIFIED DRUG; 6-OH-11-O-HYDROXYPHENANTHRENE; CATECHIN; FORKHEAD TRANSCRIPTION FACTOR; FOXO3 PROTEIN, HUMAN; PHENANTHRENE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; DRUG POTENTIATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; LYMPHOCYTE; MCF 7 CELL LINE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; BIOSYNTHESIS; BREAST NEOPLASMS; CELL PROLIFERATION; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BREAST NEOPLASMS; CATECHIN; CELL PROLIFERATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIGANDS; MCF-7 CELLS; PHENANTHRENES; RETINOID X RECEPTORS;

EID: 84903584975     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/853086     Document Type: Article

References (52)

1. Wolfram S., Effects of green tea and EGCG on cardiovascular and metabolic health. Journal of the American College of Nutrition 2007 26 4 S73 S388 2-s2.0-35348914727
2. Clement Y., Can green tea do that? A literature review of the clinical evidence. Preventive Medicine 2009 49 2-3 83 87 2-s2.0-70349272189 10.1016/j.ypmed.2009.05.005
3. Yuan J. M., Sun C., Butler L. M., Tea and cancer prevention: epidemiological studies. Pharmacological Research 2011 64 2 123 135 2-s2.0-79959560121 10.1016/j.phrs.2011.03.002
4. Kanwar J., Taskeen M., Mohammad I., Huo C., Chan T. H., Dou Q. P., Recent advances on tea polyphenols. Frontiers in Bioscience 2012 4 111 131 2-s2.0-84860845647
5. Singh B. N., Shankar S., Srivastava R. K., Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochemical Pharmacology 2011 82 12 1807 1821 2-s2.0-80555123045 10.1016/j.bcp.2011.07.093
6. Yang C. S., Wang H., Li G. X., Yang Z., Guan F., Jin H., Cancer prevention by tea: evidence from laboratory studies. Pharmacological Research 2011 64 2 113 122
7. Yang C. S., Wang H., Mechanistic issues concerning cancer prevention by tea catechins. Molecular Nutrition and Food Research 2011 55 6 819 831 2-s2.0-79958075420 10.1002/mnfr.201100036
8. Henning S. M., Niu Y., Liu Y., Lee N. H., Hara Y., Thames G. D., Minutti R. R., Carpenter C. L., Wang H., Heber D., Bioavailability and antioxidant effect of epigallocatechin gallate administered in purified form versus as green tea extract in healthy individuals. Journal of Nutritional Biochemistry 2005 16 10 610 616 2-s2.0-25144471734 10.1016/j.jnutbio.2005.03.003 (Pubitemid 41338373)
9. Lee J. H., Kishikawa M., Kumazoe M., Yamada K., Tachibana H., Vitamin A enhances antitumor effect of a green tea polyphenol on melanoma by upregulating the polyphenol sensing molecule 67-kDa laminin receptor. PLoS ONE 2010 5 6 2-s2.0-77956202733 10.1371/journal.pone.0011051 e11051
10. Mi J., Current treatment strategy of acute promyelocytic leukemia. Frontiers of Medicine in China 2011 5 4 341 347 2-s2.0-84255194993 10.1007/s11684-011-0169-z
11. Nelson J., Mcferran N. V., Pivato G., Chambers E., Doherty C., Steele D., Timson D. J., The 67 kDa laminin receptor: structure, function and role in disease. Bioscience Reports 2008 28 1 33 48 2-s2.0-46249105332 10.1042/BSR20070004
12. Tachibana H., Koga K., Fujimura Y., Yamada K., A receptor for green tea polyphenol EGCG. Nature Structural and Molecular Biology 2004 11 4 380 381 2-s2.0-1842525199 10.1038/nsmb743 (Pubitemid 38436804)
13. Umeda D., Yano S., Yamada K., Tachibana H., Green tea polyphenol epigallocatechin-3-gallate signaling pathway through 67-kDa laminin receptor. Journal of Biological Chemistry 2008 283 6 3050 3058 2-s2.0-41249088680 10.1074/jbc.M707892200
14. Umeda D., Yano S., Yamada K., Tachibana H., Involvement of 67-kDa laminin receptor-mediated myosin phosphatase activation in antiproliferative effect of epigallocatechin-3-O-gallate at a physiological concentration on Caco-2 colon cancer cells. Biochemical and Biophysical Research Communications 2008 371 1 172 176 2-s2.0-43049159573 10.1016/j.bbrc.2008.04.041
15. Anzano M. A., Byers S. W., Smith J. M., Peer C. W., Mullen L. T., Brown C. C., Roberts A. B., Sporn M. B., Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen. Cancer Research 1994 54 17 4614 4617 2-s2.0-0027982042 (Pubitemid 24276483)
16. Anzano M. A., Peer C. W., Smith J. M., Mullen L. T., Shrader M. W., Logsdon D. L., Driver C. L., Brown C. C., Roberts A. B., Sporn M. B., Chemoprevention of mammary carcinogenesis in the rat: combined use of raloxifene and 9-cis-retinoic acid. Journal of the National Cancer Institute 1996 88 2 123 125 2-s2.0-13344259303 10.1093/jnci/88.2.123 (Pubitemid 26020101)
17. Bryan M., Pulte E. D., Toomey K. C., Pliner L., Pavlick A. C., Saunders T., Wieder R., A pilot phase II trial of all-trans retinoic acid (Vesanoid) and paclitaxel (Taxol) in patients with recurrent or metastatic breast cancer. Investigational New Drugs 2011 29 6 1482 1487 2-s2.0-84856050828 10.1007/s10637-010-9478-3
18. Budd G. T., Adamson P. C., Gupta M., Homayoun P., Sandstrom S. K., Murphy R. F., McLain D., Tuason L., Peereboom D., Bukowski R. M., Ganapathi R., Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer. Clinical Cancer Research 1998 4 3 635 642 2-s2.0-15444350522 (Pubitemid 28193562)
19. Cazzaniga M., Varricchio C., Montefrancesco C., Feroce I., Guerrieri-Gonzaga A., Fenretinide (4-HPR): a preventive chance for women at genetic and familial risk? Journal of Biomedicine and Biotechnology 2012 2012 9 2-s2.0-84859731352 10.1155/2012/172897 172897
20. Wu K., Zhang Y., Xu X.-C., Hill J., Celestino J., Kim H.-T., Mohsin S. K., Hilsenbeck S. G., Lamph W. W., Bissonette R., Brown P. H., The retinoid X receptor-selective retinoid, LGD1069, prevents the development of estrogen receptor-negative mammary tumors in transgenic mice. Cancer Research 2002 62 22 6376 6380 2-s2.0-0037112520 (Pubitemid 35364089)
21. Uray I. P., Brown P. H., Chemoprevention of hormone receptor-negative breast cancer: new approaches needed. Recent Results in Cancer Research 2011 188 147 162 2-s2.0-79551513949 10.1007/978-3-642-10858-7-13
22. Bartolini G., Orlandi M., Papi A., Ammar K., Guerra F., Ferreri A. M., Rocchi P., A search for multidrug resistance modulators: the effects of retinoids in human colon carcinoma cells. In Vivo A 2006 20 6 729 734 2-s2.0-33846077187 (Pubitemid 46061610)
23. Papi A., Rocchi P., Ferreri A. M., Orlandi M., RXR γ and PPAR γ ligands in combination to inhibit proliferation and invasiveness in colon cancer cells. Cancer Letters 2010 297 1 65 74 2-s2.0-77956229623 10.1016/j.canlet.2010.04.026
24. Papi A., Guarnieri T., Storci G., Santini D., Ceccarelli C., Taffurelli M., De Carolis S., Avenia N., Sanguinetti A., Sidoni A., Orlandi M., Bonafé M., Nuclear receptors agonists exert opposing effects on the inflammation dependent survival of breast cancer stem cells. Cell Death and Differentiation 2012 19 7 1208 1219 2-s2.0-84862118662 10.1038/cdd.2011.207
25. Montesinos P., Sanz M. A., The differentiation syndrome in patients with acute promyelocytic leukemia: experience of the pethema group and review of the literature. Mediterranean Journal of Hematology and Infectious Diseases 2011 3 e2011059
26. Farabegoli F., Barbi C., Lambertini E., Piva R., (-)-Epigallocatechin-3- gallate downregulates estrogen receptor alpha function in MCF-7 breast carcinoma cells. Cancer Detection and Prevention 2007 31 6 499 504 2-s2.0-36549039923 10.1016/j.cdp.2007.10.018 (Pubitemid 350181735)
27. Romanelli S., Perego P., Pratesi G., Carenini N., Tortoreto M., Zunino F., In vitro and in vivo interaction between cisplatin and topotecan in ovarian carcinoma systems. Cancer Chemotherapy and Pharmacology 1998 41 5 385 390 2-s2.0-0031905299 10.1007/s002800050755 (Pubitemid 28095754)
28. Chomczynski P., Sacchi N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 1987 162 1 156 159 2-s2.0-0023277545 (Pubitemid 17064313)
29. Kuo C. C., Lin S. C., Altered FOXO1 transcript levels in peripheral blood mononuclear cells of systemic lupus erythematosus and rheumatoid arthritis patients. Molecular Medicine 2007 13 11-12 561 566 2-s2.0-36849073263 10.2119/2007-00021.Kuo (Pubitemid 350228716)
30. Liu L., Sun L., Zhao P., Yao L., Jin H., Liang S., Wang Y., Zhang D., Pang Y., Shi Y., Chai N., Zhang H., Zhang H., Hypoxia promotes metastasis in human gastric cancer by up-regulating the 67-kDa laminin receptor. Cancer Science 2010 101 7 1653 1660 2-s2.0-77954645380 10.1111/j.1349-7006.2010.01592.x
31. Livak K. J., Schmittgen T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001 25 4 402 408 2-s2.0-0035710746 10.1006/meth.2001.1262 (Pubitemid 34164012)
32. Scandlyn M. J., Stuart E. C., Somers-Edgar T. J., Menzies A. R., Rosengren R. J., A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate. British Journal of Cancer 2008 99 7 1056 1063 2-s2.0-53049096668 10.1038/sj.bjc.6604634
33. Chang C. M., Chang P. Y., Tu M. G., Lu C.-C., Kuo S.-C., Amagaya S., Lee C.-Y., Jao H.-Y., Chen M. Y., Yang J.-S., Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2. Oncology Reports 2012 28 5 1799 1807 2-s2.0-84866436804 10.3892/or.2012.1991
34. Tang S. N., Fu J., Shankar S., Srivastava R. K., EGCG enhances the therapeutic potential of gemcitabine and CP690550 by inhibiting STAT3 signaling pathway in human pancreatic cancer. PLoS ONE 2012 7 2 2-s2.0-84856879533 10.1371/journal.pone.0031067 e31067
35. Suganuma M., Saha A., Fujiki H., New cancer treatment strategy using combination of green tea catechins and anticancer drugs. Cancer Science 2011 102 2 317 323 2-s2.0-79952081301 10.1111/j.1349-7006.2010.01805.x
36. Singh M., Bhui K., Singh R., Shukla Y., Tea polyphenols enhance cisplatin chemosensitivity in cervical cancer cells via induction of apoptosis. Life Sciences 2013 93 1 7 16 2-s2.0-84879500539 10.1016/j.lfs.2013.02.001
37. Farabegoli F., Papi A., Orlandi M., (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells. Bioscience Reports 2011 31 2 99 108 2-s2.0-78650973015 10.1042/BSR20090143
38. Lefebvre P., Benomar Y., Staels B., Retinoid X receptors: common heterodimerization partners with distinct functions. Trends in Endocrinology and Metabolism 2010 21 11 676 683 2-s2.0-78049278719 10.1016/j.tem.2010.06.009
39. Lawrence J. A., Merino M. J., Simpson J. F., Manrow R. E., Page D. L., Steeg P. S., A high-risk lesion for invasive breast cancer, ductal carcinoma in situ, exhibits frequent overexpression of retinoid X receptor. Cancer Epidemiology Biomarkers and Prevention 1998 7 1 29 35 2-s2.0-0031908095 (Pubitemid 28087139)
40. Friedrich M., Axt-Fliedner R., Villena-Heinsen C., Tilgen W., Schmidt W., Reichrath J., Analysis of vitamin D-receptor (VDR) and retinoid X-receptor α in breast cancer. Histochemical Journal 2002 34 1-2 35 40 2-s2.0-0036379364 10.1023/A:1021343825552
41. Fang M. Z., Wang Y., Ai N., Hou Z., Sun Y., Lu H., Welsh W., Yang C. S., Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Research 2003 63 22 7563 7570 2-s2.0-0345275879 (Pubitemid 37466673)
42. Ye F., Zhang G.-H., Guan B.-X., Xu X.-C., Suppression of esophageal cancer cell growth using curcumin, (-)-epigallocatechin-3-gallate and lovastatin. World Journal of Gastroenterology 2012 18 2 126 135 2-s2.0-84862915449 10.3748/wjg.v18.i2.126
43. Gudas L. J., Wagner J. A., Retinoids regulate stem cell differentiation. Journal of Cellular Physiology 2011 226 2 322 330 2-s2.0-78649646015 10.1002/jcp.22417
44. Bianco C., Castro N. P., Baraty C., Rollman K., Held N., Rangel M. C., Karasawa H., Gonzales M., Strizzi L., Salomon D. S., Regulation of human Cripto-1 expression by nuclear receptors and DNA promoter methylation in human embryonal and breast cancer cells. Journal of Cellular Physiology 2013 228 6 1174 1188 2-s2.0-84874215066 10.1002/jcp.24271
45. Turner N. C., Reis-Filho J. S., Tackling the diversity of triple-negative breast cancer. Clinical Cancer Research 2013 19 6380 6388
46. Yang J. Y., Hung M. C., A new fork for clinical application: targeting forkhead transcription factors in cancer. Clinical Cancer Research 2009 15 3 752 757 2-s2.0-61349137083 10.1158/1078-0432.CCR-08-0124
47. Huang H., Tindall D. J., FOXO transcription factors in cell-cycle regulation and the response to oxidative stress. Future Oncology 2006 2 83 89
48. Riggins R. B., Schrecengost R. S., Guerrero M. S., Bouton A. H., Pathways to tamoxifen resistance. Cancer Letters 2007 256 1 1 24 2-s2.0-34548237309 10.1016/j.canlet.2007.03.016 (Pubitemid 47333324)
49. Eddy S. F., Kane S. E., Sonenshein G. E., Trastuzumab-resistant HER2-driven breast cancer cells are sensitive to epigallocatechin-3 gallate. Cancer Research 2007 67 19 9018 9023 2-s2.0-35148859334 10.1158/0008-5472.CAN- 07-1691 (Pubitemid 47535884)
50. Belguise K., Guo S., Sonenshein G. E., Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor α expression reversing invasive phenotype of breast cancer cells. Cancer Research 2007 67 12 5763 5770 2-s2.0-34250837002 10.1158/0008-5472.CAN-06-4327 (Pubitemid 46985009)
51. Sakoe Y., Sakoe K., Kirito K., Ozawa K., Komatsu N., FOXO3A as a key molecule for all-trans retinoic acid-induced granulocytic differentiation and apoptosis in acute promyelocytic leukemia. Blood 2010 115 18 3787 3795 2-s2.0-77952566394 10.1182/blood-2009-05-222976
52. Col J. D., Mastorci K., Fae D. A., Muraro E., Martorelli D., Inghirami G., Dolcetti R., Retinoic acid/alpha-interferon combination inhibits growth and promotes apoptosis in mantle cell lymphoma through Akt-dependent modulation of critical targets. Cancer Research 2012 72 7 1825 1835 2-s2.0-84859396088 10.1158/0008-5472.CAN-11-2505